A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the safety, PK and preliminary anti-tumour activity of SHR-A1912
combined with other therapies in patients with B-cell non-Hodgkin 's lymphoma.